Gauthé, M.; Sargos, P.; Barret, E.; Fromont-Hankard, G.; Beauval, J.-B.; Brureau, L.; Créhange, G.; Renard-Penna, R.; Dariane, C.; Fiard, G.;
et al. Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review. J. Clin. Med. 2021, 10, 4909.
https://doi.org/10.3390/jcm10214909
AMA Style
Gauthé M, Sargos P, Barret E, Fromont-Hankard G, Beauval J-B, Brureau L, Créhange G, Renard-Penna R, Dariane C, Fiard G,
et al. Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review. Journal of Clinical Medicine. 2021; 10(21):4909.
https://doi.org/10.3390/jcm10214909
Chicago/Turabian Style
Gauthé, Mathieu, Paul Sargos, Eric Barret, Gaëlle Fromont-Hankard, Jean-Baptiste Beauval, Laurent Brureau, Gilles Créhange, Raphaële Renard-Penna, Charles Dariane, Gaëlle Fiard,
and et al. 2021. "Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review" Journal of Clinical Medicine 10, no. 21: 4909.
https://doi.org/10.3390/jcm10214909
APA Style
Gauthé, M., Sargos, P., Barret, E., Fromont-Hankard, G., Beauval, J.-B., Brureau, L., Créhange, G., Renard-Penna, R., Dariane, C., Fiard, G., Mathieu, R., Roubaud, G., Ruffion, A., Rouprêt, M., Ploussard, G., & on behalf of the CC-AFU.
(2021). Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review. Journal of Clinical Medicine, 10(21), 4909.
https://doi.org/10.3390/jcm10214909